NEW HYDE PARK, N.Y.–(BUSINESS WIRE)–Northwell Health today announced the appointment of Sophy Lu as its new chief information officer (CIO). Ms. Lu, a 12-year veteran of the health system, succeeds John Bosco, who held the post from 2004 until his retirement. Ms. Lu, a senior vice president who previously served as deputy CIO, will oversee … [Read more…]
SEATTLE–(BUSINESS WIRE)–Frazier Healthcare Partners, a leading private equity and venture capital firm focused exclusively on the healthcare industry, is pleased to announce that Amy DuRoss has joined the firm’s Growth Buyout team as a Senior Advisor. In this role, Ms. DuRoss will help the firm build and execute investment strategies to serve the growing pharmaceutical … [Read more…]
YONGIN, South Korea–(BUSINESS WIRE)–GC Biopharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited consolidated financial results for the three months ended 30 June 2022. Second-Quarter Reported Results Key Figures Q2 2022 Growth(1) Total revenues KRW 423.2 billion 9.2% Operating Income KRW 13.1 billion 18.0% Net Income KRW … [Read more…]
LONDON–(BUSINESS WIRE)–#businesstravel–Many countries are recording an increase in dengue. Over the last 20 years, cases have risen more than 8 fold, impacting tens of millions of people globally1. International SOS, the world’s leading security and health services company, has seen a 92% increase in dengue-related cases this year compared to last year and therefore encourages … [Read more…]
Company Expands into Southeast with Raleigh, North Carolina Purchase ANNAPOLIS, Md.–(BUSINESS WIRE)–Thomas Park Investments closed the first half of 2022 with $75 million in medical office building (MOB) acquisitions, halfway toward the company’s goal of $150 million in acquisitions this year. The acquisitions include a purchase in Raleigh, North Carolina, signaling the company’s expansion into … [Read more…]
No dose-limiting toxicities or significant treatment-related adverse events were observed for any patient at any dose level WARREN, N.J.–(BUSINESS WIRE)–#COVID19—Tevogen Bio, a late stage clinical biotechnology company specializing in the development of cell and gene therapies in oncology, neurology, and virology, today announced that it completed enrollment in the Proof-of-Concept clinical trial of the company’s … [Read more…]
Investor Webcast and Conference Call Scheduled for 5:00 p.m. EST SAN JOSE, Calif.–(BUSINESS WIRE)–Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced clearance by the Food and Drug Administration of its previously disclosed 510(k) submission and resumption … [Read more…]
The five-year, multisite study will look at how physical activity before and after surgery affects recovery in an older patient population. LOS ANGELES–(BUSINESS WIRE)–City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that it has been approved for nearly $7 million from the Patient-Centered Outcomes Research … [Read more…]
Only Health System in the Nation to Receive National Level Recognition ONTARIO, Calif.–(BUSINESS WIRE)–#EisenbergAwards–Prime Healthcare, one of the nation’s leading health systems, has been recognized with the prestigious 2021 John M. Eisenberg Patient Safety and Quality Award in the “National Level Innovation in Patient Safety and Quality” category. Prime Healthcare was recognized for its cohesive … [Read more…]
The BrainCheck IIR Grant is looking to fund research that aids in the early detection and treatment of patient pools experiencing cognitive decline. SAN DIEGO–(BUSINESS WIRE)–BrainCheck Inc., developer of an innovative digital cognitive assessment and care platform, today announced an Investigator Initiated Research (IIR) Grant Program to help fund research for evaluation, diagnosis, treatment and … [Read more…]
